BBOTVSBTAI• 3 Months (Normalized)
BBOT vs BTAI (BridgeBio Oncology Therapeutics Inc. vs BioXcel Therapeutics Inc.)
Showing Closing Date Range from Jul 4 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-53.75%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
BTAI Performance $0.04
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
-53.75 pts
BTAI outperforming by 53.75 percentage points
BBOTBTAI
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT BTAI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | BBOT Price | BBOT Gain (%) | BTAI Price | BTAI Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -53.75% | $- | - | |
| Sep 30, 2026 | $4.10 | -51.25% | $- | - | |
| Sep 29, 2026 | $3.92 | -53.39% | $- | - | |
| Sep 28, 2026 | $3.81 | -54.70% | $- | - | |
| Sep 25, 2026 | $3.95 | -53.03% | $- | - | |
| Sep 24, 2026 | $3.99 | -52.56% | $0.04 | -96.79% | +44.23% |
| Sep 23, 2026 | $4.16 | -50.54% | $0.05 | -95.91% | +45.37% |
| Sep 22, 2026 | $4.66 | -44.59% | $0.04 | -95.95% | +51.36% |
| Sep 21, 2026 | $4.66 | -44.59% | $0.06 | -94.41% | +49.82% |
| Sep 18, 2026 | $4.77 | -43.28% | $0.06 | -94.73% | +51.45% |
| Sep 17, 2026 | $4.89 | -41.85% | $0.08 | -93.17% | +51.32% |
| Sep 16, 2026 | $4.76 | -43.40% | $0.07 | -93.92% | +50.52% |
| Sep 15, 2026 | $4.88 | -41.97% | $0.04 | -95.94% | +53.97% |
| Sep 14, 2026 | $5.05 | -39.95% | $0.05 | -95.90% | +55.95% |
| Sep 11, 2026 | $4.95 | -41.14% | $0.05 | -95.36% | +54.22% |
Page 1 of 5